Sebivo and blood bilirubin unconjugated increased Patient Reports February 10, 2010
Sebivo Side Effects Report #5504045-X
Sebivo side effect was reported by a Consumer or non-health professional from CHINA on Oct 24, 2007. Female patient was diagnosed with hepatitis b
and was treated with Sebivo. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, cholelithiasis, mobility decreased, pain
, poor quality sleep, protein total decreased, pruritus. Sebivo dosage: 600 MG, QD. During the same period patient was treated with HUGANNING, URSO FALK, ORYZANOL. Patient recovered.Sebivo Side Effects Report #5504693-7
Sebivo side effect was reported by a Consumer or non-health professional from CHINA on Oct 24, 2007. Female patient was diagnosed with hepatitis b
and was treated with Sebivo. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, cholelithiasis, mobility decreased, pain
, poor quality sleep, protein total decreased, pruritus. Sebivo dosage: 600 MG, QD. During the same period patient was treated with HUGANNING, URSO FALK, ORYZANOL. Patient recovered.Sebivo Side Effects Report #5840687-X
Sebivo side effect was reported by a Physician from CHINA on Aug 04, 2008. Female patient was diagnosed with hepatitis b
and was treated with Sebivo. After drug was administered, patient experienced the following side effects: acidosis, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood lactate dehydrogenase increased. Sebivo dosage: 600 MG QD. Patient was hospitalized. Patient died on 08/04/2008.Sebivo Side Effects Report #5931963-0
Sebivo side effect was reported by a Physician from CHINA on Oct 21, 2008. Male patient, weighting 130.1 lb, was diagnosed with hepatitis b
and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood gases abnormal. Sebivo dosage: 600 MG QD. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient died on 08/04/2008.
Sebivo and blood bilirubin unconjugated increased 